President & Chief Executive Officer
Allan is President & Chief Executive Officer (CEO) of Apotex. In this role, Allan leads a global workforce of almost 8,000 employees and the operations of Apotex around the globe in more than 115 countries.
Allan brings four decades of experience in corporate leadership to Apotex, including 20 years in the pharmaceutical industry. Most recently, he served as CEO of Concordia International Corp. and CEO of Sagent Pharmaceuticals Inc. Prior to these positions, he served as President and CEO of Teva Canada (formerly Novopharm Limited), COO of Teva International Group, President of Teva EMIA and President and CEO of Teva Americas Generics. His extensive experience includes strategy development, transformational business growth, execution excellence, international market expansion and global partnerships.
Mr. Oberman has almost three decades of corporate governance experience, having served on numerous boards, including as Chairman of the Canadian Generic Pharmaceutical Association and Vice-Chairman of the U.S. Association for Accessible Medicines. He has an MBA from the Schulich School of Business, York University, and a BA from Western University.
Managing Director, Latin America
Américo García joined the Apotex® team in 2014 as Managing Director for Latin America (LATAM). Under his leadership are the finished product operations, supply chain, research and development, and the medicines marketing for the LATAM region, where he has contributed with a strategic approach based on a participative leadership.
He has held various positions within the Pharmaceutical Industry as well as several executive posts in multinational companies such as Deloitte Consulting, Organon in Mexico, Colombia, Peru, and Ecuador; Bayer Healthcare in its Regional Office for Latin America and Hospira as Managing Director for Latin America.
Américo is a graduate of ITESM and holds a Master's Degree in Business Administration and Leadership from the DUXX Business School and the INSEAD Business School of France.